GNAQ and T-cell non-Hodgkin lymphoma: Remarkably, recurrent loss‐of‐function (LOF) mutations at Y101or T96S or loss of Gαq expression affect the expression of the Gαq pathway in nearly 25% of natural killer (NK)/T/T cell lymphoma, an extremely malignant and highly aggressive subtype of non‐Hodgkin's lymphoma [140].